Testing

Our comprehensive testing for celiac disease and inflammatory bowel disease evaluates patients suspected of having celiac disease, including patients with compatible symptoms, patients with atypical symptoms, and individuals at increased risk. We also offer a variety of interactive, step-by-step algorithms that provide the most appropriate selection of tests for each patient, while maintaining the highest possible sensitivity and specificity.

By mayocliniclabs • April 20, 2012

Over 1 million hips are implanted each year worldwide. Adverse reaction to metal debris (ARMD) occurs in a small number of patients with metal-on-metal hip replacements. Evaluation of serum chromium and cobalt concentration can help determine the degree of metal-on-metal orthopedic implant deterioration.

By mayocliniclabs • October 7, 2011

Mayo Clinic offers a test to assess for biliary tract malignancy through the combination of cytology and molecular testing by fluorescence in situ hybridization (FISH).

By Brent Westra • July 11, 2011

Full content can be viewed here.

By Brent Westra • June 17, 2011

Full content can be viewed here.

By Brent Westra • May 23, 2011

R. Jeffrey Karnes, M.D., addresses the controversy over PSA test use and its effectiveness in prostate cancer screening and discusses what constitutes the best screening methods and programs.

By Brent Westra • April 13, 2011

The CellSearch Circulating Tumor Cell (CTC) test is a simple blood test that helps oncologists in assessing the prognosis of patients with metastatic breast, colorectal, or prostate cancer.

By Brent Westra • November 4, 2010

Autoantibody tests performed on serum and spinal fluid aid in the diagnosis of autoimmune disorders of the brain, nerve, and muscle that are often a reflection of immune responses initiated by unsuspected cancer.

By Brent Westra • September 2, 2010

Full content can be viewed here.

By Brent Westra • March 16, 2010